世界中の市場調査レポートを販売!当社に無いレポートもお探しします。

レポートナンバー 0000032682

ボツリヌス毒素市場規模、シェア、動向分析レポート、予測2022-2030

Grand View Research Inc.

Botulinum Toxin Market Size, Share & Trends Analysis Report, And Segment Forecasts, 2022 - 2030

発刊日 2022/07

言語英語

体裁PDF/100ページ

ライセンス/価格100ページ

0000032682

Individual
Team
Enterprise

※ご請求は、お申込日のTTSレートで円換算し、消費税を加えた金額になります。
※本レポートは、英文です。PDF(電子媒体)での納品となります。
※本レポートは取り寄せとなりますので、申し込みからお届けまで、多少時間が掛かる場合がございます。

無料サンプル

  • サンプルはお問い合わせください。

レポート概要

ボツリヌス毒素市場の規模、シェア、動向分析レポート:製品の種類別(タイプA、タイプB)、用途別(治療、審美)、最終用途別、地域別、およびセグメント予、2022〜2030

レポートの概要
世界のボツリヌス毒素市場規模は2021年に58億ドルと評価され、2022年から2030年までに11.5%のCAGRで拡大すると予想されます。ボツリヌス毒素は、ボツリヌス菌によって産生されるタンパク質および神経毒です。毒素は、神経から放出されるアセチルコリンの選択的遮断薬であり、筋肉に注射されると神経からの神経伝達を遮断します。ボツリヌス毒素は、医学と科学で遭遇する最も例外的な物質の1つです。美容におけるボツリヌス毒素の普及は、10年間で急速に拡大し、現在世界で最も一般的で広く行われている審美的処置の1つとなっています。先進地域および発展途上地域においてその審美的特性に対する関心が高まっていることが、美容目的の処置件数の増加につながっています。

レポート詳細

目次

Table of Contents

Chapter 1 Methodology and Scope
1.1 Market Segmentation & Scope
1.1.1 Product Type
1.1.2 Application
1.1.3 End-Use
1.1.4 Regional Scope
1.1.5 Estimates And Forecast Timeline
1.2 Research Methodology
1.3 Information Procurement
1.3.1 Purchased Database
1.3.2 Gvr’s Internal Database
1.3.3 Secondary Sources
1.3.4 Primary Research
1.3.5 Details Of Primary Research
1.4 Information or Data Analysis
1.4.1 Data Analysis Models
1.5 Market Formulation & Validation
1.6 Model Details
1.6.1 Commodity Flow Analysis (Model 1)
1.7 List of Secondary Sources
1.8 List of Primary Sources
1.9 List of Abbreviations
1.10 Objectives
1.10.1 Objective - 1:
1.10.2 Objective - 2:
1.10.3 Objective - 3:
1.10.4 Objective - 4:

Chapter 2 Executive Summary
2.1 Market Outlook

Chapter 3 Botulinum Toxin Market: Variables, Trends, & Scope
3.1 Market Segmentation and Scope
3.2 Market Dynamics
3.2.1 Market Driver Analysis
3.2.2.1 Increasing Number Of Patients Having Neurological Disorders
3.2.2.2 Rising Preference For Non-Invasive Or Minimally Invasive Procedures
3.2.2.3 Increasing Concern Regarding Aesthetic Appearance In 40-54 Age Group Has Increased The Adoption Rate
3.2.2 Market Restraint Analysis
3.2.2.1 High cost of cosmetic procedure
3.3 Penetration & Growth Prospect Mapping
3.4 Botulinum Toxin: Market Analysis Tools
3.4.1 Industry Analysis - Porter’s
3.4.2 Pestel Analysis

Chapter 4 Botulinum Toxin Market: Product Type Segment Analysis
4.1 Botulinum Toxin: Product type Market Share Analysis, 2021 & 2030
4.2 Type A
4.2.1 Type A Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
4.3 Type B
4.3.1 Type B Market Estimates And Forecasts, 2018 - 2030 (USD Billion)

Chapter 5 Botulinum Toxin Market: Application Segment Analysis
5.1 Botulinum Toxin: Application Market Share Analysis, 2021 & 2030
5.2 Therapeutic
5.2.1 Therapeutic Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
5.3 Aesthetic
5.3.1 Aesthetic Market Estimates And Forecasts, 2018 - 2030 (USD Billion)

Chapter 6 Botulinum Toxin Market: End-use Segment Analysis
6.1 Botulinum Toxin: End-use Market Share Analysis, 2021 & 2030
6.2 Hospitals
6.2.1 Hospitals Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
6.3 Dermatology Clinics
6.3.1 Dermatology Clinics Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
6.4 Spas and Cosmetic Centers
6.4.1 Spas and Cosmetic Centers Market Estimates And Forecasts, 2018 - 2030 (USD Billion)

Chapter 7 Botulinum Toxin Market: Regional Analysis
7.1 Botulinum Toxin: Regional Market Share Analysis, 2021 & 2030
7.2 North America
7.2.1 North America Botulinum Toxin Market, 2018 - 2030 (USD Billion)
7.2.2 U.S.
7.2.2.1 U.S. Botulinum Toxin Market, 2018 - 2030 (USD Billion)
7.2.3 Canada
7.2.3.1 Canada Botulinum Toxin Market, 2018 - 2030(USD Billion)
7.3 Europe
7.3.1 Europe Botulinum Toxin Market, 2018 - 2030 (USD Billion)
7.3.2 U.K.
7.3.2.1 U.K. Botulinum Toxin Market, 2018 - 2030 (USD Billion)
7.3.3 Germany
7.3.3.1 Germany Botulinum Toxin Market, 2018 - 2030 (USD Billion)
7.3.4 France
7.3.4.1 France Botulinum Toxin Market, 2018 - 2030 (USD Billion)
7.3.5 Italy
7.3.5.1 Italy Botulinum Toxin Market, 2018 - 2030 (USD Billion)
7.3.6 Spain
7.3.6.1 Spain Botulinum Toxin Market, 2018 - 2030 (USD Billion)
7.4 Asia Pacific
7.4.1 Asia Pacific Botulinum Toxin Market, 2018 - 2030 (USD Billion)
7.4.2 China
7.4.2.1 China Botulinum Toxin Market, 2018 - 2030 (USD Billion)
7.4.3 India
7.4.3.1 India Botulinum Toxin Market, 2018 - 2030 (USD Billion)
7.4.4 Japan
7.4.4.1 Japan Botulinum Toxin Market, 2018 - 2030 (USD Billion)
7.4.5 South Korea
7.4.5.1 South Korea Botulinum Toxin Market, 2018 - 2030 (USD Billion)
7.4.6 Australia
7.4.6.1 Australia Botulinum Toxin Market, 2018 - 2030 (USD Billion)
7.5 Latin America
7.5.1 Latin America Botulinum Toxin Market, 2018 - 2030 (USD Billion)
7.5.2 Brazil
7.5.2.1 Brazil Botulinum Toxin Market, 2018 - 2030 (USD Billion)
7.5.3 Mexico
7.5.3.1 Mexico Botulinum Toxin Market, 2018 - 2030 (USD Billion)
7.5.4 Argentina
7.5.4.1 Argentina Botulinum Toxin Market,2018 - 2030 (USD Billion)
7.6 MEA
7.6.1 MEA Botulinum Toxin Market, 2018 - 2030 (USD Billion)
7.6.2 South Africa
7.6.2.1 South Africa Botulinum Toxin Market, 2018 - 2030 (USD Billion)
7.6.3 Saudi Arabia
7.6.3.1 Saudi Arabia Botulinum Toxin Market, 2018 - 2030 (USD Billion)
7.6.4 UAE
7.6.4.1 UAE Botulinum Toxin Market, 2018 - 2030 (USD Billion)

Chapter 8 Company Profiles
8.1 IPSEN GROUP
8.1.1 Company overview
8.1.2 Financial performance
8.1.3 Product benchmarking
8.1.4 Strategic initiatives
8.2 ALLERGEN INC.
8.2.1 Company overview
8.2.2 Financial performance
8.2.3 Product Benchmarking
8.2.4 Strategic initiatives
8.3 MEDY-TOX, INC.
8.3.1 Company overview
8.3.2 Financial performance
8.3.3 Product benchmarking
8.3.4 Strategic initiatives
8.4 METABIOLOGICS
8.4.1 Company overview
8.4.2 Financial performance
8.4.3 Strategic initiatives
8.5 MERZ PHARMA
8.5.1 Company overview
8.5.2 Financial performance
8.5.3 Product benchmarking
8.5.4 Strategic initiatives
8.6 US WORLDMEDS
8.6.1 Company overview
8.6.2 Financial performance
8.6.3 Product benchmarking
8.6.4 Strategic initiatives
8.7 EVOLUS
8.7.1 Company overview
8.7.2 Financial performance
8.7.3 Product benchmarking
8.7.4 Strategic initiatives
8.8 GALDERMA
8.8.1 Company overview
8.8.2 Financial performance
8.8.3 Product benchmarking
8.8.4 Strategic initiatives
8.9 LANZHOU INSTITUTE OF BIOLOGICAL PRODUCTS
8.9.1 Company overview
8.9.2 Financial performance
8.9.3 Product benchmarking
8.9.4 Strategic initiatives

List of Tables
Table 1 List of secondary sources
Table 2 List of Abbreviations
Table 3 Strategic collaborations by key players

List of Figures
Fig. 1 Market research process
Fig. 2 Information procurement
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 Value-chain-based sizing & forecasting
Fig. 6 QFD modeling for market share assessment
Fig. 7 Market formulation & validation
Fig. 8 Commodity flow analysis
Fig. 9 Botulinum Toxin Market snapshot (2021)
Fig. 10 Botulinum Toxin Market segmentation
Fig. 11 Market driver relevance analysis (Current & future impact)
Fig. 12 Market restraint relevance analysis (Current & future impact)
Fig. 13 Penetration & growth prospect mapping
Fig. 14 Porter’s five forces analysis
Fig. 15 SWOT analysis, by factor (political & legal, economic and technological)
Fig. 16 Botulinum toxin market product type outlook: Segment dashboard
Fig. 17 Botulinum toxin market: product type movement analysis
Fig. 18 Type A market, 2018 - 2030 (USD Billion)
Fig. 19 Type B market, 2018 - 2030 (USD Billion)
Fig. 20 Botulinum toxin market application outlook: Segment dashboard
Fig. 21 Botulinum Toxin Market: Application movement analysis
Fig. 22 Therapeutic market, 2018 - 2030 (USD Billion)
Fig. 23 Aesthetic market, 2018 - 2030 (USD Billion)
Fig. 24 Botulinum toxin market end-use outlook: Segment dashboard
Fig. 25 Botulinum Toxin Market: End-use movement analysis
Fig. 26 Hospitals market, 2018 - 2030 (USD Billion)
Fig. 27 Dermatology clinics market, 2018 - 2030 (USD Billion)
Fig. 28 Spas and cosmetic centers market, 2018 - 2030 (USD Billion)
Fig. 29 Regional market: Key takeaways
Fig. 30 Regional outlook: 2021& 2030
Fig. 31 North America market, 2018 - 2030 (USD Billion)
Fig. 32 U.S. market, 2018 - 2030 (USD Billion)
Fig. 33 Canada market, 2018 - 2030 (USD Billion)
Fig. 34 Europe market, 2018 - 2030
Fig. 35 U.K. market, 2018 - 2030 (USD Billion)
Fig. 36 Germany market, 2018 - 2030 (USD Billion)
Fig. 37 France market, 2018 - 2030 (USD Billion)
Fig. 38 Italy market,2018 - 2030 (USD Billion)
Fig. 39 Spain market, 2018 - 2030 (USD Billion)
Fig. 40 Asia Pacific market, 2018 - 2030 (USD Billion)
Fig. 41 China market, 2018 - 2030 (USD Billion)
Fig. 42 Japan market, 2018 - 2030 (USD Billion)
Fig. 43 India market, 2018 - 2030 (USD Billion)
Fig. 44 South Korea market, 2018 - 2030 (USD Billion
Fig. 45 Australia market, 2018 - 2030 (USD Billion
Fig. 46 Latin America market, 2018 - 2030 (USD Billion)
Fig. 47 Brazil market, 2018 - 2030 (USD Billion)
Fig. 48 Mexico market, 2018 - 2030 (USD Billion)
Fig. 49 Argentina market, 2018 - 2030 (USD Billion)
Fig. 50 MEA market, 2018 - 2030 (USD Billion)
Fig. 51 South Africa market, 2018 - 2030 (USD Billion)
Fig. 52 Saudi Arabia market, 2018 - 2030 (USD Billion)
Fig. 53 UAE market, 2018 - 2030 (USD Billion)

この商品のレポートナンバー

0000032682

TOP